{
  "timeline": [
    {
      "date": "1935",
      "tags": [
        "設備投資"
      ],
      "category": "設備投資",
      "region": "",
      "importance": 2,
      "event": "大阪市東淀川区下新庄町（現・東淀川区下新庄）に淀川工場（大阪工場）を開設。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "1944",
      "tags": [],
      "category": "",
      "region": "",
      "importance": 1,
      "event": "本社（東区北浜（現・中央区北浜））を淀川工場敷地内に移転。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "1945/3",
      "tags": [],
      "category": "",
      "region": "",
      "importance": 2,
      "event": "営業内容を明確に表示するため商号に製薬の名称を入れ参天堂製薬株式会社に変更。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "1958/6",
      "tags": [
        "新規事業"
      ],
      "category": "新規事業",
      "region": "",
      "importance": 3,
      "event": "新たに医療用医薬品発売を契機として商号を参天製薬株式会社と変更。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "1963/11",
      "tags": [
        "株式上場"
      ],
      "category": "株式上場",
      "region": "",
      "importance": 3,
      "event": "大阪証券取引所市場第二部に上場。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "1964/4",
      "tags": [
        "株式上場"
      ],
      "category": "株式上場",
      "region": "",
      "importance": 2,
      "event": "東京証券取引所市場第二部に上場。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "1970/10",
      "tags": [],
      "category": "",
      "region": "",
      "importance": 1,
      "event": "本社社屋を建設。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "1977/10",
      "tags": [
        "株式上場"
      ],
      "category": "株式上場",
      "region": "",
      "importance": 3,
      "event": "東京証券取引所・大阪証券取引所の市場第一部に上場。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "1985/1",
      "tags": [
        "設備投資"
      ],
      "category": "設備投資",
      "region": "",
      "importance": 2,
      "event": "石川県羽咋郡志雄町（現・宝達志水町）に能登工場を開設。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "1992/5",
      "tags": [
        "設備投資"
      ],
      "category": "設備投資",
      "region": "",
      "importance": 1,
      "event": "能登工場第2棟を増設。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "1993/1",
      "tags": [
        "海外進出"
      ],
      "category": "海外進出",
      "region": "米州",
      "importance": 2,
      "event": "米国・カリフォルニア州ナパにSanten Inc.（現・連結子会社）を設立。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "1996/4",
      "tags": [
        "海外進出"
      ],
      "category": "海外進出",
      "region": "中国",
      "importance": 1,
      "event": "中国・北京に北京事務所を開設。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "1996/4",
      "tags": [
        "研究開発",
        "設備投資"
      ],
      "category": "研究開発|設備投資",
      "region": "",
      "importance": 2,
      "event": "奈良県生駒市に奈良R&Dセンター眼科研究所（現・奈良研究開発センター）を開設。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "1996/7",
      "tags": [
        "設備投資"
      ],
      "category": "設備投資",
      "region": "",
      "importance": 2,
      "event": "滋賀県犬上郡多賀町に滋賀工場（現・滋賀プロダクトサプライセンター）を開設。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "1996/10",
      "tags": [
        "設備投資"
      ],
      "category": "設備投資",
      "region": "",
      "importance": 1,
      "event": "能登工場第3棟を増設。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "1997/2",
      "tags": [
        "海外進出",
        "設備投資"
      ],
      "category": "海外進出|設備投資",
      "region": "欧州",
      "importance": 2,
      "event": "フィンランド・タンペレに医薬品製造会社Santen Oy（現・連結子会社）を設立。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "1997/3",
      "tags": [
        "企業買収",
        "海外進出"
      ],
      "category": "企業買収|海外進出",
      "region": "欧州",
      "importance": 3,
      "event": "フィンランドの眼科薬メーカー、スターを買収。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2001/11",
      "tags": [
        "企業買収",
        "海外進出"
      ],
      "category": "企業買収|海外進出",
      "region": "米州",
      "importance": 2,
      "event": "米国の眼科医療機器会社Advanced Vision Science, Inc.（現・連結子会社）を買収。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2002/1",
      "tags": [
        "組織再編"
      ],
      "category": "組織再編",
      "region": "米州",
      "importance": 1,
      "event": "米国・カリフォルニア州ナパに持株会社Santen Holdings U.S. Inc.（現・連結子会社）を設立。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2002/11",
      "tags": [
        "設備投資"
      ],
      "category": "設備投資",
      "region": "",
      "importance": 1,
      "event": "奈良研究開発センター北棟を増設。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2003/9",
      "tags": [
        "設備投資"
      ],
      "category": "設備投資",
      "region": "",
      "importance": 1,
      "event": "滋賀工場（現・滋賀プロダクトサプライセンター）第2棟が操業開始。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2005/9",
      "tags": [
        "海外進出"
      ],
      "category": "海外進出",
      "region": "中国",
      "importance": 2,
      "event": "中国・蘇州に参天製薬（中国）有限公司（現・連結子会社）を設立。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2008/11",
      "tags": [
        "設備投資"
      ],
      "category": "設備投資",
      "region": "",
      "importance": 1,
      "event": "奈良研究開発センターに製剤開発棟および新付属棟を増設。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2011/7",
      "tags": [],
      "category": "",
      "region": "米州",
      "importance": 1,
      "event": "Santen Holdings U.S. Inc.およびSanten Inc.の本社所在地を米国・カリフォルニア州ナパからエメリービルへ移転。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2011/7",
      "tags": [
        "海外進出"
      ],
      "category": "海外進出",
      "region": "その他",
      "importance": 1,
      "event": "インド・バンガロールにSanten India Private Limited（現・連結子会社）を設立。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2011/10",
      "tags": [
        "企業買収",
        "海外進出"
      ],
      "category": "企業買収|海外進出",
      "region": "欧州",
      "importance": 3,
      "event": "フランスの眼科医薬品会社Novagali Pharma S.A.（連結子会社）を買収。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2012/3",
      "tags": [
        "組織再編"
      ],
      "category": "組織再編",
      "region": "欧州",
      "importance": 1,
      "event": "オランダ・アムステルダムに持株会社Santen Holdings EU B.V.（現・連結子会社）を設立。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2012/3",
      "tags": [],
      "category": "",
      "region": "欧州",
      "importance": 1,
      "event": "Novagali Pharma S.A.の会社形態の変更により、Novagali Pharma S.A.S.（連結子会社）へ変更。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2013/3",
      "tags": [
        "設備投資"
      ],
      "category": "設備投資",
      "region": "",
      "importance": 1,
      "event": "滋賀工場（現・滋賀プロダクトサプライセンター）中央棟を増設。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2013/4",
      "tags": [],
      "category": "",
      "region": "欧州",
      "importance": 1,
      "event": "Novagali Pharma S.A.S.の社名をSanten S.A.S.（現・連結子会社）へ変更。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2013/6",
      "tags": [],
      "category": "",
      "region": "",
      "importance": 1,
      "event": "本社機能を大阪市東淀川区から大阪市北区へ移転。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2013/9",
      "tags": [
        "海外進出"
      ],
      "category": "海外進出",
      "region": "中国",
      "importance": 1,
      "event": "中国・蘇州に参天医薬販売（蘇州）有限公司（現・連結子会社）を設立。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2013/10",
      "tags": [
        "海外進出"
      ],
      "category": "海外進出",
      "region": "東南アジア",
      "importance": 1,
      "event": "ベトナム・ホーチミンにホーチミン事務所を開設。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2013/12",
      "tags": [
        "海外進出"
      ],
      "category": "海外進出",
      "region": "東南アジア",
      "importance": 1,
      "event": "シンガポールにSanten Pharmaceutical Asia Pte. Ltd.（現・連結子会社）を設立。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2014/7",
      "tags": [
        "企業買収",
        "海外進出"
      ],
      "category": "企業買収|海外進出",
      "region": "",
      "importance": 3,
      "event": "Merck & Co., Inc.が有する眼科用医薬品およびこれらの製品に関連する権利等一式を譲り受け。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2014/7",
      "tags": [
        "海外進出"
      ],
      "category": "海外進出",
      "region": "欧州",
      "importance": 1,
      "event": "イタリア・ミラノにSanten Italy S.r.l.（現・連結子会社）を設立。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2014/8",
      "tags": [
        "海外進出"
      ],
      "category": "海外進出",
      "region": "欧州",
      "importance": 1,
      "event": "スイス・ジュネーブにSanten Switzerland SA（連結子会社）、イギリス・サリーにSanten UK Limited（現・連結子会社）を設立。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2014/10",
      "tags": [
        "海外進出"
      ],
      "category": "海外進出",
      "region": "東南アジア",
      "importance": 1,
      "event": "フィリピン・マカティにSANTEN PHILIPPINES INC.（現・連結子会社）、タイ・バンコクにSANTEN (THAILAND) CO., LTD.（現・連結子会社）を設立。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2014/11",
      "tags": [
        "海外進出"
      ],
      "category": "海外進出",
      "region": "東南アジア",
      "importance": 1,
      "event": "マレーシア・プタリンジャヤにSANTEN PHARMA MALAYSIA SDN. BHD.（現・連結子会社）を設立。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2014/12",
      "tags": [
        "海外進出"
      ],
      "category": "海外進出",
      "region": "欧州",
      "importance": 1,
      "event": "スペイン・マドリードにSanten Pharmaceutical Spain, S.L.（現・連結子会社）を設立。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2015/8",
      "tags": [
        "事業売却"
      ],
      "category": "事業売却",
      "region": "",
      "importance": 3,
      "event": "抗リウマチ薬事業をあゆみ製薬株式会社へ承継。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2016/4",
      "tags": [],
      "category": "",
      "region": "",
      "importance": 1,
      "event": "大阪市東淀川区に参天ビジネスサービス株式会社（連結子会社）を設立。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2016/5",
      "tags": [
        "新規事業"
      ],
      "category": "新規事業",
      "region": "",
      "importance": 1,
      "event": "大阪市東淀川区に参天アイケア株式会社（現・連結子会社）を設立。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2016/6",
      "tags": [
        "海外進出"
      ],
      "category": "海外進出",
      "region": "中国",
      "importance": 1,
      "event": "中国・香港に参天製薬（香港）有限公司（現・連結子会社）を設立。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2016/8",
      "tags": [
        "企業買収",
        "海外進出"
      ],
      "category": "企業買収|海外進出",
      "region": "米州",
      "importance": 3,
      "event": "米国の医療用デバイス開発会社InnFocus, Inc.（現・連結子会社）を買収。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2016/8",
      "tags": [
        "合弁設立",
        "海外進出"
      ],
      "category": "合弁設立|海外進出",
      "region": "中国",
      "importance": 2,
      "event": "中国・重慶に合弁会社、重慶参天科瑞製薬有限公司（現・連結子会社）を設立。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2017/2",
      "tags": [
        "海外進出"
      ],
      "category": "海外進出",
      "region": "その他",
      "importance": 1,
      "event": "ロシア・モスクワにSANTEN LIMITED LIABILITY COMPANY（現・連結子会社）を設立。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2017/7",
      "tags": [
        "新規事業"
      ],
      "category": "新規事業",
      "region": "米州",
      "importance": 1,
      "event": "米国・カリフォルニア州エメリービルにSanten Ventures, Inc.（現・連結子会社）を設立。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2018/2",
      "tags": [],
      "category": "",
      "region": "欧州",
      "importance": 1,
      "event": "Santen Switzerland SAの社名をSanten SA（現・連結子会社）へ変更。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2018/4",
      "tags": [],
      "category": "",
      "region": "東南アジア",
      "importance": 1,
      "event": "ホーチミン事務所をSanten Pharmaceutical Asia Pte. Ltd.（現・連結子会社）へ移管。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2018/12",
      "tags": [
        "資産圧縮"
      ],
      "category": "資産圧縮",
      "region": "",
      "importance": 1,
      "event": "旧本社・大阪工場跡地を売却。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2019/2",
      "tags": [
        "海外進出"
      ],
      "category": "海外進出",
      "region": "米州",
      "importance": 1,
      "event": "カナダ・オンタリオ州トロントにSanten Canada Inc.（現・連結子会社）を設立。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2019/9",
      "tags": [
        "資産圧縮"
      ],
      "category": "資産圧縮",
      "region": "欧州",
      "importance": 2,
      "event": "Santen Oy（現・連結子会社）のタンペレ工場をNextPharma Oyへ譲渡。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2020/1",
      "tags": [],
      "category": "",
      "region": "",
      "importance": 1,
      "event": "登記上の本店所在地を大阪市東淀川区から大阪市北区へ移転。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2020/8",
      "tags": [
        "合弁設立",
        "海外進出"
      ],
      "category": "合弁設立|海外進出",
      "region": "米州",
      "importance": 2,
      "event": "米国のVerily Life Sciences LLCと合弁会社Twenty Twenty Therapeutics LLC（持分法適用関連会社）を設立。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2020/9",
      "tags": [
        "企業買収",
        "海外進出"
      ],
      "category": "企業買収|海外進出",
      "region": "米州",
      "importance": 2,
      "event": "米国の点眼用眼科製品開発・販売会社Eyevance Pharmaceuticals Holdings Inc.（現・連結子会社）およびその事業会社であるEyevance Pharmaceuticals LLC（現・連結子会社）を買収。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2020/9",
      "tags": [
        "海外進出"
      ],
      "category": "海外進出",
      "region": "中国",
      "importance": 1,
      "event": "中国・上海に参天投資（中国）有限公司（現・連結子会社）を設立。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2020/10",
      "tags": [
        "海外進出"
      ],
      "category": "海外進出",
      "region": "東南アジア",
      "importance": 1,
      "event": "ベトナム・ホーチミンにSanten Pharmaceutical Vietnam Co., Ltd.（現・連結子会社）を設立。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2021/10",
      "tags": [],
      "category": "",
      "region": "東南アジア",
      "importance": 1,
      "event": "シンガポールのPlano Pte. Ltd.（現・持分法適用関連会社）に対する議決権比率が20％以上となったため持分法を適用。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2022/3",
      "tags": [
        "資産圧縮"
      ],
      "category": "資産圧縮",
      "region": "",
      "importance": 1,
      "event": "大阪市東淀川区の自社ビル下新庄オフィスを売却。SantenPharma AB（連結子会社）を清算結了。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2022/4",
      "tags": [
        "株式上場"
      ],
      "category": "株式上場",
      "region": "",
      "importance": 1,
      "event": "東京証券取引所の市場区分の見直しにより、市場第一部からプライム市場に移行。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2023/6",
      "tags": [
        "設備投資"
      ],
      "category": "設備投資",
      "region": "",
      "importance": 1,
      "event": "滋賀プロダクトサプライセンター第3棟が操業開始。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2023/7",
      "tags": [
        "事業売却",
        "海外撤退"
      ],
      "category": "事業売却|海外撤退",
      "region": "米州",
      "importance": 3,
      "event": "米州における医療用医薬品事業に係る一部製品をHarrow Health, Inc.へ資産譲渡。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2024/7",
      "tags": [],
      "category": "",
      "region": "",
      "importance": 1,
      "event": "参天ビジネスサービス株式会社（連結子会社）を清算結了。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    },
    {
      "date": "2025/3",
      "tags": [],
      "category": "",
      "region": "米州",
      "importance": 1,
      "event": "Twenty Twenty Therapeutics LLC（持分法適用関連会社）を清算配当の受領により持分法適用関連会社から除外。",
      "detail": "",
      "significance": "",
      "source": "有価証券報告書"
    }
  ]
}